attachment

Give answer

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
This is a classic pharmacology experiment. Here are the answers:

1. Drug Used at Point X

Phentolamine (or phenoxybenzamine — a non-selective α-adrenergic receptor blocker)
This is the standard "Dale's vasomotor reversal" / "Epinephrine Reversal" experiment. The drug given at point X is an α-adrenergic blocker (classically phentolamine or phenoxybenzamine).
How to read the figure:
  • Panel 1 (before X): Epinephrine (A) causes a BP rise; Norepinephrine (B) also causes a rise — both intact α responses.
  • Panel 2 (point X): The α-blocker is administered. Notice a flat/depressed BP trace — basal BP falls.
  • Panel 3 (after X): Epinephrine (A) now lowers BP (reversal!); Norepinephrine (B) still raises BP (only diminished, not reversed).

2. Type of Drug Interaction

Epinephrine Reversal (Dale's Vasomotor Reversal)
This is a pharmacodynamic drug interaction — specifically receptor-level antagonism (competitive or non-competitive blockade):
FeatureExplanation
Mechanismα-blocker blocks α₁ receptors on vascular smooth muscle
Epinephrine after α-blockα₁ vasoconstriction is blocked; unmasked β₂ vasodilation causes BP to fall (reversal)
Norepinephrine after α-blockNot reversed — only diminished, because NE has negligible β₂ vasodilatory activity
Isoproterenol (pure β agonist)Would be unaffected by the α-blocker
The interaction is pharmacodynamic antagonism at the receptor level — the α-blocker selectively removes the pressor (α₁) component of epinephrine, leaving the depressor (β₂) component unopposed, reversing the net BP effect.
Source: Katzung's Basic and Clinical Pharmacology, 16th Ed. (Figure 10-3); Lippincott Illustrated Reviews Pharmacology, p. 254–255

No any 3rd panel

Looking at the image again carefully:
The figure has only 2 panels separated by point X:
  • Panel 1 (left): Epinephrine (A) and Norepinephrine (B) given → both cause BP rise (peaks visible around 160 mmHg)
  • Point X: Drug is administered (single injection, flat tracing briefly)
  • Panel 2 (right): Epinephrine (A) and Norepinephrine (B) given again → both still cause BP rise, but notice the responses are enhanced/exaggerated — peaks now reach ~180-200 mmHg
This pattern — where both epinephrine and norepinephrine show augmented pressor responses after drug X — indicates that drug X is a neuronal uptake blocker (Uptake-1 blocker).

1. Drug at Point X

Cocaine (or alternatively imipramine/desipramine — a Uptake-1/NET blocker)
The classic answer in pharmacology experiments is Cocaine, which blocks the norepinephrine transporter (NET/Uptake-1), preventing reuptake of catecholamines → potentiates and prolongs the pressor effects of both epinephrine and norepinephrine.

2. Type of Drug Interaction

Pharmacokinetic potentiation via inhibition of neuronal reuptake (Uptake-1 blockade)
FeatureExplanation
MechanismCocaine blocks NET (norepinephrine transporter) on sympathetic nerve terminals
EffectMore catecholamine remains in synapse → enhanced receptor activation
ResultPressor responses to both Epi and NE are augmented
Interaction typePharmacokinetic (disposition/reuptake) → functional potentiation
This is the cocaine-catecholamine potentiation experiment, a classic demonstration of Uptake-1 blockade in pharmacology.
This is a shared conversation. Sign in to Orris to start your own chat.